Rubhana Raqib et al.
Human vaccines & immunotherapeutics, 15(6), 1326-1337 (2019-02-23)
Shigella sonnei live vaccine candidate, WRSS1, which was previously evaluated in US, Israeli and Thai volunteers, was administered orally to Bangladeshi adults and children to assess its safety, clinical tolerability and immunogenicity. In a randomized, placebo-controlled, dose-escalation, age-descending study, 39